FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)

View source ↗

Summary

FDA approved a supplemental application for RAMIPRIL submitted by Chartwell RX, LLC., indicating approval of a supplemental filing related to RAMIPRIL.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Ischemic Heart Disease
• Myocardial Infarction

Drugs mentioned

• Ramipril (ramipril)

Snippet

SUPPL AP for RAMIPRIL (RAMIPRIL)